The impact of next-generation sequencing in immunogenetics: Current status and future directions

Valia Bravo-Egana, Dimitri Monos

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Purpose of review: Next-generation sequencing (NGS) has now been established, and widely recognized, to be the preferred choice for human leukocyte antigen (HLA) typing. This transformation is based upon the many scientific, operational and economic benefits this technology affords. In this report, we review the major advantages, existing limitations and significant promise derived from adopting this technology in immunogenetics. Recent findings: Significant benefits have emerged from the usage of NGS in a relatively short period, whereby we realize that this technology not only helps addressing the technical and operational problems we have had with the legacy methods for HLA typing, but equally important, it also allows for creative applications in stem cell and organ transplantation, new ways to investigate associations of the major histocompatibility complex (MHC) with many diseases and enhance our understanding regarding the MHC and non-MHC genomic interactions. The emerging picture is one of significant benefits in the diagnostic sphere of immunogenetics and transplantation and one of interconnectivity, integrating the many biological pathways controlled and affected by this unique genomic region. Summary: NGS has revolutionized the science and practice of immunogenetics. In this article, we identify the still unresolved issues, the current benefits to transplantation and the potential for dissecting the complexity of the MHC, one of the most fascinating regions of the human genome. Using current trends, an attempt is made to predict future directions and outcomes.

Original languageEnglish (US)
Pages (from-to)400-406
Number of pages7
JournalCurrent Opinion in Organ Transplantation
Volume22
Issue number4
DOIs
StatePublished - Aug 1 2017
Externally publishedYes

Fingerprint

Immunogenetics
Major Histocompatibility Complex
HLA Antigens
Technology
Transplantation
Stem Cell Transplantation
Organ Transplantation
Human Genome
Economics
Direction compound

Keywords

  • bone marrow transplantation
  • human leukocyte antigens
  • major histocompatibility complex
  • next-generation sequencing
  • solid organ transplantation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation

Cite this

The impact of next-generation sequencing in immunogenetics : Current status and future directions. / Bravo-Egana, Valia; Monos, Dimitri.

In: Current Opinion in Organ Transplantation, Vol. 22, No. 4, 01.08.2017, p. 400-406.

Research output: Contribution to journalReview article

@article{565862ba453f4f0195acc3fde9fc7a17,
title = "The impact of next-generation sequencing in immunogenetics: Current status and future directions",
abstract = "Purpose of review: Next-generation sequencing (NGS) has now been established, and widely recognized, to be the preferred choice for human leukocyte antigen (HLA) typing. This transformation is based upon the many scientific, operational and economic benefits this technology affords. In this report, we review the major advantages, existing limitations and significant promise derived from adopting this technology in immunogenetics. Recent findings: Significant benefits have emerged from the usage of NGS in a relatively short period, whereby we realize that this technology not only helps addressing the technical and operational problems we have had with the legacy methods for HLA typing, but equally important, it also allows for creative applications in stem cell and organ transplantation, new ways to investigate associations of the major histocompatibility complex (MHC) with many diseases and enhance our understanding regarding the MHC and non-MHC genomic interactions. The emerging picture is one of significant benefits in the diagnostic sphere of immunogenetics and transplantation and one of interconnectivity, integrating the many biological pathways controlled and affected by this unique genomic region. Summary: NGS has revolutionized the science and practice of immunogenetics. In this article, we identify the still unresolved issues, the current benefits to transplantation and the potential for dissecting the complexity of the MHC, one of the most fascinating regions of the human genome. Using current trends, an attempt is made to predict future directions and outcomes.",
keywords = "bone marrow transplantation, human leukocyte antigens, major histocompatibility complex, next-generation sequencing, solid organ transplantation",
author = "Valia Bravo-Egana and Dimitri Monos",
year = "2017",
month = "8",
day = "1",
doi = "10.1097/MOT.0000000000000422",
language = "English (US)",
volume = "22",
pages = "400--406",
journal = "Current Opinion in Organ Transplantation",
issn = "1087-2418",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The impact of next-generation sequencing in immunogenetics

T2 - Current status and future directions

AU - Bravo-Egana, Valia

AU - Monos, Dimitri

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Purpose of review: Next-generation sequencing (NGS) has now been established, and widely recognized, to be the preferred choice for human leukocyte antigen (HLA) typing. This transformation is based upon the many scientific, operational and economic benefits this technology affords. In this report, we review the major advantages, existing limitations and significant promise derived from adopting this technology in immunogenetics. Recent findings: Significant benefits have emerged from the usage of NGS in a relatively short period, whereby we realize that this technology not only helps addressing the technical and operational problems we have had with the legacy methods for HLA typing, but equally important, it also allows for creative applications in stem cell and organ transplantation, new ways to investigate associations of the major histocompatibility complex (MHC) with many diseases and enhance our understanding regarding the MHC and non-MHC genomic interactions. The emerging picture is one of significant benefits in the diagnostic sphere of immunogenetics and transplantation and one of interconnectivity, integrating the many biological pathways controlled and affected by this unique genomic region. Summary: NGS has revolutionized the science and practice of immunogenetics. In this article, we identify the still unresolved issues, the current benefits to transplantation and the potential for dissecting the complexity of the MHC, one of the most fascinating regions of the human genome. Using current trends, an attempt is made to predict future directions and outcomes.

AB - Purpose of review: Next-generation sequencing (NGS) has now been established, and widely recognized, to be the preferred choice for human leukocyte antigen (HLA) typing. This transformation is based upon the many scientific, operational and economic benefits this technology affords. In this report, we review the major advantages, existing limitations and significant promise derived from adopting this technology in immunogenetics. Recent findings: Significant benefits have emerged from the usage of NGS in a relatively short period, whereby we realize that this technology not only helps addressing the technical and operational problems we have had with the legacy methods for HLA typing, but equally important, it also allows for creative applications in stem cell and organ transplantation, new ways to investigate associations of the major histocompatibility complex (MHC) with many diseases and enhance our understanding regarding the MHC and non-MHC genomic interactions. The emerging picture is one of significant benefits in the diagnostic sphere of immunogenetics and transplantation and one of interconnectivity, integrating the many biological pathways controlled and affected by this unique genomic region. Summary: NGS has revolutionized the science and practice of immunogenetics. In this article, we identify the still unresolved issues, the current benefits to transplantation and the potential for dissecting the complexity of the MHC, one of the most fascinating regions of the human genome. Using current trends, an attempt is made to predict future directions and outcomes.

KW - bone marrow transplantation

KW - human leukocyte antigens

KW - major histocompatibility complex

KW - next-generation sequencing

KW - solid organ transplantation

UR - http://www.scopus.com/inward/record.url?scp=85019586354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019586354&partnerID=8YFLogxK

U2 - 10.1097/MOT.0000000000000422

DO - 10.1097/MOT.0000000000000422

M3 - Review article

C2 - 28509679

AN - SCOPUS:85019586354

VL - 22

SP - 400

EP - 406

JO - Current Opinion in Organ Transplantation

JF - Current Opinion in Organ Transplantation

SN - 1087-2418

IS - 4

ER -